Attend the event here: – LOS ANGELES, CA, May 21, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), clinical-stage biopharmaceutical company developing ...

What: Erlanger Trauma Services will host its annual Trauma Symposium at the Chattanooga Convention Center on Thursday, May 22 ...

Bill Horrigan, a curator who built Ohio's Wexner Center for the Arts into a destination for film and video art, in the ...

While the results bolster efficacy, questions remain about high costs and other issues with the ATTR-CM therapies.

Intellia Therapeutics (NTLA) announced positive two-year follow-up data from the ongoing Phase 1 trial of investigational nexiguran ziclumeran, ...

The Chattanooga Heart Institute at CHI Memorial announced the opening a new center aimed at detecting and treating an often ...

Alnylam (ALNY) says its heart disease drug Amvuttra caused a 36% reduction in mortality in a Phase 3 trial for ATTR ...

In a follow up to his recent appearance on the Business of Biotech, Tolga Tanguler explains how Alnylam is positioning ...

Steve Pepoon, an Emmy Award-winning television writer who worked on The Simpsons and other series, has died at the age of 68.

An Emmy winner and the pride of Paola, Kansas, he also worked on ‘It’s Garry Shandling’s Show,’ ‘Roseanne’ and two series ...

Prothena Corp. PLC company and executive profile by Barron's. View the latest PRTA company infomation and executive bios.

Diagnosis of ATTRv disease will be evaluated as the primary analysis of the study - In the ACT-EARLY study, BridgeBio will partner globally with ATTR amyloidosis treating physicians and patient ...